Proteome Sciences (PRM)

 

PRM Share PerformanceMore

52 week high11.2500 20/10/16
52 week low2.6100 18/10/17
52 week change -7.4750 (-70.35%)
4 week volume5,944,194 23/09/17

Media for (PRM)

Presenter: Christopher Pearce
30/05/2014

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

GCLP Accreditation and Trading Update

RNS Number: 8705T Proteome Sciences PLC 18 October 2017 18 October 2017 Proteome Sciences plc ("Proteome Sciences" or the "Company") GCLP Accreditation and Trading Update The Company is pleased to announce the receipt of Good Clinical Laboratory Practice (GCLP) accreditation which will now enable it to compete effectively for clinical stage contracts co...

Block Admission Return

RNS Number: 5841S Proteome Sciences PLC 03 October 2017 Proteome Sciences plc Block Admission return Name of company: Proteome Sciences plc Name of scheme: 2004 Share Option Plan 2011 Share Option Plan Period of return: 1 April 2017 to 30 September 2017 Number of ordinary shares of 1 pence each in the company ("Ordinary Shares") not issued under the...

Proteome issues shares

Proteome Sciences confirmed that it has issued and allotted 533,333 ordinary shares as payment for professional services. At...

Issue of Equity

RNS Number: 6020P Proteome Sciences PLC 01 September 2017 1 September2017 Proteome Sciences plc ("Proteome Sciences" or the "Company") Issue of Equity Proteome Sciences (AIM:PRM), announces that it has today issued and allotted 533,333 ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") as payment for professional services. Applic...

Directorate Changes

RNS Number: 6491M Proteome Sciences PLC 01 August 2017 1 August 2017 Proteome Sciences plc ("Proteome Sciences" or the "Company") Directorate changes Proteome Sciences (AIM:PRM), is pleased to announce the appointment of Dr Ursula Ney as a Non-executive Director of the Company, with immediate effect, replacing Professor William Dawson who is stand...

Interim results for the 6 months to 30 June 2017

RNS Number: 9512L Proteome Sciences PLC 25 July 2017 25 July 2017 Proteome Sciences plc ("Proteome Sciences" or the "Company") Interim results for the six months ended 30 June 2017 Proteome Sciences is pleased to announce its unaudited interim results for the six months ended 30 June 2017. Financial highlights: Total revenues increased 21% to 1.36m (2016: 1.12m)...

Proteome schedules interim results release date

Proteome Sciences has confirmed that the Company will announce its interim results for the six months ended 30 June on...

Notice of Results

RNS Number: 7216K Proteome Sciences PLC 11 July 2017 Proteome Sciences plc ("Proteome Sciences" or the "Company") Notice of Results Proteome Sciences will announce its interim results for the six months ended 30 June 2017 on 25 July 2017. For further information: Proteome Sciences plc Dr Jeremy Haigh, Chief Executive Officer Tel: +44 (0)20 7043 2116 Dr Ian P...

Fundamental DataMore

EPS-0.96
Dividend yield0 %

Latest discussion posts More

  • Re: Confession

    Yes it was 175p (roughy) in late Decemner 2003, Ah the good old days!!! Sentiment has certainy taken a hit (understandably - given the poor performance and lack of revenues!), ...
    3-Sep-2017
    Andy Reilly
  • Re: Confession

    BC2000, Sorry, my mistake. TP
    1-Sep-2017
    The Potter
  • Re: Confession

    ??? What income from Sandoz are you referring to? They produce Biosimilars and Generics and have no motivation for proteomics, at least that is my understanding. Please ...
    31-Aug-2017
    Bluechip2000

Users' HoldingsMore

Users who hold Proteome Sciences also hold..
LLOYDS GRP.22%
BARCLAYS14%
BP13%
GLAXOSMITHKLINE13%
VODAFONE GRP.13%

Codes & Symbols

ISINGB0003104196
SymbolsPRM, LSE:PRM, PRM.L, PRM:LN, LON:PRM, XLON:PRM